Project Grant R21NS145050
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$475K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This $600,878 Project Grant was awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The grant supports research to identify the baseline factors determining migraine prognosis in adolescents and characterize the hormonal, neural, and psychophysical changes related to migraine prognosis during puberty. Key objectives include determining if male...
This federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the role of the GPR37L1 receptor in chronic migraine-like states. The total award of $419,375 was granted to Florida Atlantic University, with a sub-award to the University of Florida, over the project period of July 10, 2024 to June 30, 2026. The key objectives of the research are to: 1)...
This federal Project Grant award, totaling $370,440.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant aims to characterize the longitudinal relationship between migraine and affective disorders, with a focus on understanding how hormonal fluctuations across the lifespan influence this comorbidity. The research will be conducted by Dr. Crowe at Brigham & Women's Hospital, a subsidiary of the Partners...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will support research focused on understanding the molecular mechanisms underlying migraines and temporomandibular disorders (TMDs), and evaluating S1P receptor 1 (S1PR1) as a novel therapeutic target. The $620,278 award to the University of Maryland, Baltimore will fund a...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $455,371 to the University of California, Los Angeles (UCLA) to develop and validate a novel microchip-based system for continuous recording and triggering of neurovascular activity and behavior. The goal is to establish this platform as a novel tool for the discovery and characterization of new migraine therapies....
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,325,500 to develop novel PAC1 receptor antagonists for the treatment of medication overuse headache (MOH). The project aims to leverage a collaborative research effort between the Pradhan, Katritch, and Majumdar labs to identify and characterize promising lead compounds targeting the PAC1 receptor, which plays a key...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $470,786 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The project, titled "Aging Immunity to Extracellular Mitochondria Exacerbates Vascular Cognitive Impairment After Stroke," aims to investigate the mechanisms by which...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $1,421,976.00 to the Massachusetts Institute of Technology (MIT) to conduct research on the neural mechanisms underlying sickness behaviors. The key objective is to identify the dorsal raphe nucleus (DRN) and its associated neural circuits as the primary targets of...
This federal Project Grant award of $798,848 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to examine the influence of the skull bone marrow niche on brain health and post-stroke inflammation. The research will investigate the information transfer between the central nervous system and the skull marrow, which acts as a specialized producer...
The National Institutes of Health's National Institute on Aging awarded a $2,366,184 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital, to support research into the mechanisms of circadian and synaptic dysfunction after repetitive mild traumatic brain injury. The three-year award, made on June 1, 2022 under the Aging Research program (CFDA 93.866), will fund work by Drs. Whalen and Lipton to define how interleukin-1 receptor 1-mediated...